Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Angiodynamics Inc (ANGO)

Angiodynamics Inc (ANGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 438,137
  • Shares Outstanding, K 41,217
  • Annual Sales, $ 292,500 K
  • Annual Income, $ -33,990 K
  • EBIT $ -22 M
  • EBITDA $ 4 M
  • 60-Month Beta 0.47
  • Price/Sales 1.49
  • Price/Cash Flow 21.70
  • Price/Book 2.47

Options Overview Details

View History
  • Implied Volatility 59.83% (+2.69%)
  • Historical Volatility 61.62%
  • IV Percentile 29%
  • IV Rank 30.18%
  • IV High 109.77% on 03/21/25
  • IV Low 38.24% on 10/23/25
  • Expected Move (DTE 28) 1.19 (11.46%)
  • Put/Call Vol Ratio 0.03
  • Today's Volume 322
  • Volume Avg (30-Day) 453
  • Put/Call OI Ratio 0.14
  • Today's Open Interest 2,703
  • Open Int (30-Day) 3,907
  • Expected Range 9.19 to 11.57

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 02/28/26
See More
  • Average Estimate -0.09
  • Number of Estimates 2
  • High Estimate -0.08
  • Low Estimate -0.11
  • Prior Year 0.03
  • Growth Rate Est. (year over year) -400.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.72 +6.79%
on 01/12/26
13.37 -22.36%
on 01/05/26
-2.78 (-21.12%)
since 12/23/25
3-Month
9.72 +6.79%
on 01/12/26
13.99 -25.80%
on 12/04/25
-1.62 (-13.50%)
since 10/23/25
52-Week
8.27 +25.51%
on 03/11/25
13.99 -25.80%
on 12/04/25
-2.07 (-16.63%)
since 01/23/25

Most Recent Stories

More News
AngioDynamics: Fiscal Q2 Earnings Snapshot

AngioDynamics: Fiscal Q2 Earnings Snapshot

ANGO : 10.38 (-2.35%)
AngioDynamics Reports Fiscal Year 2026 Second Quarter Financial Results; Continued Double Digit Med Tech Growth Drives Increased Profitability

Med Tech segment delivers fifth consecutive quarter of double-digit growth Strong adjusted EBITDA; and positive cash flow Three regulatory milestones support Mechanical...

ANGO : 10.38 (-2.35%)
AngioDynamics to Report Fiscal 2026 Second Quarter Results on January 6, 2026

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and...

ANGO : 10.38 (-2.35%)
AngioDynamics to Present at the 44th Annual J.P. Morgan Healthcare Conference

AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality...

ANGO : 10.38 (-2.35%)
AngioDynamics to Participate in the UBS Global Healthcare Conference

AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality...

ANGO : 10.38 (-2.35%)
AngioDynamics’ NanoKnife® System Named to TIME’s 2025 Best Inventions List

Function-Preserving Therapy Recognized in the Medical Devices Category for its Use of Irreversible Electroporation (IRE) Technology in Treatment of Prostate Tumors

ANGO : 10.38 (-2.35%)
AngioDynamics Reports Strong Growth in Earnings Call

Angiodynamics, Inc. ((ANGO)) has held its Q1 earnings call. Read on for the main highlights of the call. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful...

ANGO : 10.38 (-2.35%)
AngioDynamics Reports Strong Q1 2026 Growth

Angiodynamics, Inc. ( (ANGO) ) has released its Q1 earnings. Here is a breakdown of the information Angiodynamics, Inc. presented to its investors.Elevate Your Investing Strategy: Take advantage of TipRanks...

ANGO : 10.38 (-2.35%)
AngioDynamics Reports Strong Q1 2026 Financial Results

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An update...

ANGO : 10.38 (-2.35%)
Stocks Settle Higher as Chip Makers and AI Infrastructure Stocks Rally

The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.17%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.37%. December E-mini...

MSTR : 163.11 (+1.32%)
AMAT : 322.38 (+1.13%)
MDLZ : 58.40 (+1.42%)
AVGO : 320.05 (-1.67%)
BE : 144.89 (-0.51%)
GLXY : 31.90 (+3.17%)
SLB : 49.15 (-0.34%)
TXN : 193.31 (-0.86%)
ANGO : 10.38 (-2.35%)
$IUXX : 25,605.47 (+0.34%)
COIN : 216.95 (-2.77%)
ASML : 1,389.04 (-0.43%)

Business Summary

AngioDynamics Inc. designs, manufactures and sells a wide range of medical, surgical and diagnostic devices. The devices are generally used in minimally invasive, image-guided procedures. AngioDynamics product offerings fall within three Global Business Units, namely Oncology/Surgery, Endovascular Therapies...

See More

Key Turning Points

3rd Resistance Point 10.92
2nd Resistance Point 10.81
1st Resistance Point 10.59
Last Price 10.38
1st Support Level 10.26
2nd Support Level 10.15
3rd Support Level 9.93

See More

52-Week High 13.99
Fibonacci 61.8% 11.80
Fibonacci 50% 11.13
Fibonacci 38.2% 10.46
Last Price 10.38
52-Week Low 8.27

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar